Nova Mentis Life Science (Nova Mentis Life Science) Market Cap : $2.17 Mil (As of Jun. 08, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Nova Mentis Life Science Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nova Mentis Life Science's share price for the quarter that ended in Mar. 2024 was $0.014. Nova Mentis Life Science's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 148.32 Mil. Therefore, Nova Mentis Life Science's market cap for the quarter that ended in Mar. 2024 was $2.08 Mil.

Nova Mentis Life Science's quarterly market cap declined from Mar. 2023 ($6.07 Mil) to Sep. 2023 ($2.74 Mil) and declined from Sep. 2023 ($2.74 Mil) to Mar. 2024 ($2.08 Mil).

Nova Mentis Life Science's annual market cap declined from Dec. 2020 ($18.69 Mil) to Dec. 2021 ($4.75 Mil) but then increased from Dec. 2021 ($4.75 Mil) to Dec. 2022 ($10.16 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nova Mentis Life Science's Enterprise Value for Today is $2.20 Mil.

Nova Mentis Life Science Market Cap Historical Data

The historical data trend for Nova Mentis Life Science's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Mentis Life Science Market Cap Chart

Nova Mentis Life Science Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Market Cap

Get a 7-Day Free Trial

8.91

5.14

18.69

4.75

10.16

Nova Mentis Life Science Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Mar24
Market Cap	Get a 7-Day Free Trial															4.15	10.16	6.07	2.74	2.08

Competitive Comparison of Nova Mentis Life Science's Market Cap

For the Biotechnology subindustry, Nova Mentis Life Science's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Mentis Life Science's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nova Mentis Life Science's Market Cap distribution charts can be found below:

* The bar in red indicates where Nova Mentis Life Science's Market Cap falls into.

Nova Mentis Life Science Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Nova Mentis Life Science's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$0.07	*	145.119
	=	$10.16

Nova Mentis Life Science's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	$0.014	*	148.319
	=	$2.08

Nova Mentis Life Science (OTCPK:NMLSF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Nova Mentis Life Science Market Cap Related Terms

Thank you for viewing the detailed overview of Nova Mentis Life Science's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Mentis Life Science (Nova Mentis Life Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nova Mentis Life Science Corp (OTCPK:NMLSF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

HN3Q:Germany NOVA:Canada

Address

700-838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6

Website

https://www.novamentis.ca

Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS). The company's goal is to diagnose and treat debilitating chronic conditions that have unmet medical needs such as autism spectrum disorder (ASD) and FXS. It has one industry segment, being research and development of psilocybin, and in one geographic area, which is Canada.